Please use this identifier to cite or link to this item:
|Title:||The controlled presentation of TGF-β1 to hepatocytes in a 3D-microfluidic cell culture system|
|Authors:||Zhang, C. |
van, Noort D.
|Keywords:||3D cell constructs|
Transforming growth factor
|Source:||Zhang, C.,Ong, S.-M.,Zhang, S.,Toh, Y.-C.,van, Noort D.,Yu, H.,Chia, S.-M. (2009). The controlled presentation of TGF-β1 to hepatocytes in a 3D-microfluidic cell culture system. Biomaterials 30 (23-24) : 3847-3853. ScholarBank@NUS Repository. https://doi.org/10.1016/j.biomaterials.2009.03.052|
|Abstract:||3D-microfluidic cell culture systems (3D-μFCCSs) support hepatocyte functions in vitro which can be further enhanced by controlled presentation of 100-200 pg/ml TGF-β1, thus mimicking the roles of supporting cells in co-cultures. Controlled presentation of TGF-β1 is achieved by either direct perfusion or in situ controlled release from gelatin microspheres immobilized in the 3D-μFCCS. Primary hepatocytes cultured for 7 days with the in situ controlled released TGF-β1 exhibited up to four-fold higher albumin secretion and two-fold higher phase I/II enzymatic activities, significantly improving the sensitivity of hepatocytes to acetaminophen-mediated hepatotoxicity, compared to hepatocytes cultured with directly perfused TGF-β1 or without TGF-β1. The controlled presentation of TGF-β1 enhanced hepatocyte functions in microfluidic systems without the complications of co-cultures, allowing for simplifications in drug testing and other hepatocyte-based applications. © 2009 Elsevier Ltd. All rights reserved.|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on Dec 5, 2017
WEB OF SCIENCETM
checked on Nov 8, 2017
checked on Dec 9, 2017
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.